Difference in electron microscopic findings among interstitial cystitis/bladder pain syndrome with distinct clinical and cystoscopic characteristics

Urothelial dysfunction may be a key pathomechanism underlying interstitial cystitis/bladder pain syndrome (IC/BPS). We therefore examined if clinical severity is associated with the extent of urothelial damage as revealed by electron microscopic (EM) analysis of biopsy tissue. One hundred IC/BPS patients were enrolled and 24 patients with stress urinary incontinence served as controls. Clinical symptoms were evaluated by visual analog scale pain score and O’Leary-Sant Symptom score. Bladder biopsies were obtained following cystoscopic hydrodistention. The presence of Hunner’s lesions and glomerulation grade after hydrodistention were recorded and patients classified as Hunner-type IC (HIC) or non-Hunner-type IC (NHIC). HIC patients exhibited more severe defects in urothelium cell layers, including greater loss of umbrella cells, umbrella cell surface uroplakin plaque, and tight junctions between adjacent umbrella cells, compared to control and NHIC groups (all p < 0.05). Both NHIC and HIC groups demonstrated more severe lamina propria inflammatory cell infiltration than controls (p = 0.011, p < 0.001, respectively). O’Leary-Sant Symptom scores were significantly higher among patients with more severe urothelial defects (p = 0.030). Thus, urothelium cell layer defects on EM are associated with greater clinical symptom severity.


Scientific Reports
| (2021) 11:17258 | https://doi.org/10.1038/s41598-021-96810-w www.nature.com/scientificreports/ of umbrella cells constituting the outer cell layer, loss of surface microvilli, and mast cell activation [12][13][14] . The loss of umbrella cells and reduced cell membrane microplicae on EM have been associated with clinical symptoms 15 . However, these studies did not distinguish changes unique to NHIC and HIC subgroups or assess the associations between such changes and cystoscopic characteristics. Therefore, the aim of the current study is to investigate differences in urothelial EM findings among IC/BPS patients with distinct clinical and cystoscopic characteristics following cystoscopic hydrodistention.

Methods
Patient enrolment. We prospectively enrolled IC/BPS patients admitted to our hospital for diagnostic cystoscopic hydrodistention and intravesical treatment from August 2016 to December 2019. All patients were diagnosed with IC/BPS according to the 2008 European Society for the Study of Interstitial Cystitis criteria 1 .
Patients with confusable diseases such as bladder cancer, acute or chronic urinary tract infection, urolithiasis, bladder outlet obstruction, and neurogenic voiding dysfunction were excluded. Patients who had undergone urological procedures within the previous 3 months, such as cystoscopic hydrodistention or intravesical instillation of any therapeutic agent, were also excluded. Female patients with stress urinary incontinence but stable bladder function admitted for anti-incontinence surgery were offered enrolment as controls.
Ethics declaration. The present study was approved by the institutional review board and ethics committee of Buddhist Tzu Chi General Hospital (IRB number 108-45A). All methods were performed in accordance with the relevant guidelines and regulations. Written informed consent was obtained from all patients and control subjects before enrolment.
Diagnosis and symptom evaluation. After admission to the hospital, all patients received a comprehensive medical interview and physical examination. A 10-point visual analog scale (VAS) was used to evaluate bladder pain severity, while the O'Leary-Sant Symptom (OSS) questionnaire was used to evaluate symptoms and problems. All patients received video urodynamic studies to confirm IC/BPS diagnosis and exclude other conditions such as bladder outlet obstruction, detrusor overactivity, and neurogenic bladder dysfunction. All IC/ BPS patients then underwent diagnostic cystoscopic hydrodistention under general anesthesia at an intravesical pressure of 80 cmH 2 O. Patients were subsequently classified as NHIC or HIC based on the presence of Hunner's lesions. The maximal bladder capacity (MBC) and the grade of glomerulation (Nordling et al. classification) were also recorded 16 . Three cold-cup biopsies were obtained from the posterior bladder wall after hydrodistention, followed by adequate electrocauterized hemostasis. The specimens were prepared for EM investigation using the same protocol as described in our previous study 15 and the defects were graded using a 4-point scale as follows: 0, normal; 1, mild defect; 2, moderate defect; 3, severe defect.
Statistical analyses. The frequencies of cystoscopic characteristics identified by EM were compared between patient groups using the chi-square test. Patients were also stratified according to the severity of urothelial defects on EM (none, mild, or moderate vs. severe). Differences in quantitative symptom parameters (VAS, OSS, CBC, and MBC) were compared between these groups using the Independent t-test. A p < 0.05 (two-tailed) was considered significant for all tests. All analyses were performed using SPSS for Windows, version 16.0 (SPSS, Chicago, IL).

Results
One  Figure 1 presents transmission EM (TEM) images of the urothelium cell layer in biopsy samples from patients with different defect grades. The normal urothelium (grade 0) consisted of 3-6 cell layers above the basement membrane with an intact umbrella (outer) cell layer (Fig. 1a). Subsequence urothelium cell layer defects grade  Fig. 1b,c, while some HIC cases exhibited severe urothelium denudation and basement membrane exposure (Fig. 1d). High-power TEM of control and NHIC biopsy samples revealed that the umbrella cell surface was covered with numerous uroplakin plaques and small vesicles (Fig. 2a). In contrast, HIC patient samples exhibited a smooth umbrella cell surface without uroplakin plaques or vesicles (Fig. 2b). Epithelial layer integrity conferred by intercellular tight junctions also differed among samples from patient groups stratified by defect grades on EM (Fig. 3). Normal urothelium (grade 0) showed no gaps between adjacent umbrella cells ( Fig. 3a), while patients with grades 1-3 demonstrated progressively greater tight junction defects characterized by more numerous and wider lateral interstitial spaces between adjacent umbrella cells ( Fig. 3b-d). Similarly, EM findings demonstrated different abnormalities in individual urothelial cell morphology (Fig. 4), with cells of grade 0 samples exhibiting intact cytoplasmic organelles and nuclei (Fig. 4a), whereas some patient samples exhibited apoptotic urothelial cells featuring lysed organelles and swollen nuclei (Fig. 4b). www.nature.com/scientificreports/ A comparison of these ultrastructural defects among controls and IC/BPS patient subgroups (Fig. 5) revealed more frequent urothelium cell layer defects among HIC patients compared to controls and NHIC patients (p = 0.004 and p = 0.001, respectively, by chi-square test) as well as more frequent breaches in umbrella cell layer integrity (p = 0.013 and p = 0.008, respectively), loss of umbrella cell surface uroplakin plaques (p = 0.001 and p < 0.001, respectively), and loss of tight junctions between adjacent umbrella cells (p = 0.018 and p = 0.012, respectively). Both NHIC and HIC groups exhibited more frequent lamina propria inflammatory cell infiltration compared to controls (p = 0.011 and p < 0.001, respectively), and infiltration was actually more common in the NHIC group than the HIC group (p = 0.004). Alternatively, the overall frequency of lysed organelles did not differ among the three groups.
Subgroup analysis of NHIC patients revealed significantly more frequent lamina propria inflammatory cell infiltration in those with severe glomerulation (p < 0.001) ( Table 2). Further, patients with more frequent urothelium cell layer deficits also had significantly higher OSS scores (p = 0.030) ( Table 3), while patients with more urothelial cell lysed organelles had significantly lower OSS scores (p = 0.003). Other associations between IC/ BPS symptom parameters and EM findings are presented in Table 3.

Discussion
In this study, we compared urothelial ultrastructural defects among NHIC, HIC, and control biopsy samples as well as between IC/BPS patient subgroups stratified by glomerulation grade. These analyses revealed more frequent or severe urothelial deficits among HIC patients than NHIC patients or control subjects as well as greater lamina propria inflammatory cell infiltration among NHIC patients with more severe glomerulation. Further, urothelial cell defects were associated with greater symptom severity according to OSS score. Collectively, these observations strongly suggest that urothelial dysfunction is a major determinant of IC/BPS clinical severity.
Interstitial cystitis/bladder pain syndrome is usually divided into NHIC and HIC subtypes according to the presence of Hunner's lesion on cystoscopic examination 9,10 . Histological abnormalities are easily identified in HIC bladder samples, and include obvious inflammatory changes and urothelial denudation, while NHIC bladder histology is difficult to differentiate from normal bladder histology 11 . Several previous EM studies have also described pathologic changes in bladder ultrastructure among IC/BPS patients, such denudation and loss of urothelial cell layers in HIC 9,17 , as well increased apoptotic activity and urothelial barrier defects due to downregulation of tight junction proteins such as E-cadherin and ZO-1 7,18 . However, these studies did not investigate associations with clinical features or cystoscopic characteristics following hydrodistention. Here, we confirm that urothelial dysfunction progresses with disease severity. Notably, patients with HIC exhibited a greater reduction in urothelial cell layers, more extensive loss of umbrella cells, and fewer tight junctions, while the urothelial ultrastructure of NHIC patients resembled that of control subjects, underscoring the distinct pathophysiology of HIC and NHIC. The management of HIC is relatively straightforward, as many studies have reported significant pain relief after transurethral electroablation or partial cystectomy of Hunner lesions 19,20 . In contrast, the optimal management of NHIC is uncertain. Therefore, distinguishing HIC from NHIC is critical. In the current study, HIC patients always demonstrated higher clinical symptom scores and more severe urothelial defects.
Our previous EM study of IC/BPS bladder ultrastructure demonstrated that the severity of umbrella cell loss and the decrease in membrane microplicae were associated with clinical symptom severity as assessed by VAS, CBC, and MBC 15 . However, in the present larger-scale study, we found that only patients with severe urothelium cell layer deficits had significantly higher OSS scores (p = 0.030), possibly due to the higher ratio of NHIC to HIC patients (9:1) compared to our previous work (7:3). An ICDB (Interstitial Cystitis Database) study, demonstrated   21 . These findings are consisted with current EM study. Uroplakin plaque disruption is considered a biomarker for urothelial dysfunction in IC/BPS 5 . Disruption of uroplakin plaques destroys the integrity of the urothelial barrier and increases urothelial permeability, resulting in IC/BPS symptoms 22 . For instance, a previous study demonstrated significantly reduced Uroplakin-III in the bladders of IC/BPS patients compared to a control group 23 . Alternatively, Cho et al. 24 found Uroplakin-III elevation in the non-ulcerative portion of HIC bladder, which may reflect a compensatory upregulation. A study of bladder samples from ulcerative lesions in HIC obtained 5 min after cystoscopic hydrodistention reported significantly lower expression levels of UP-Ia, -Ib, -II, and -III, while Uroplakin-III and III-delta4 genes were significantly upregulated in patients with NHIC 25 . In the current study, uroplakin defects were significantly more severe in HIC patients than control and NHIC groups but did not differ between control and NHIC groups. Our Bladder permeability barrier function is maintained by the apical membrane, tight junctions between urothelial cells, and by active trafficking mechanisms 26,27 Umbrella cells located at the apical layer of the bladder provide uroplakins for enhanced tissue flexibility, form the first tight junction-dense barrier, and contribute to active transport 5 , so processes that damage umbrella cells will lead to a dramatic loss of barrier integrity 28 . In turn, leakage of urine into the underlying suburothelial layer activates sensory receptors, resulting in irritative bladder symptoms and hypersensitivity to filling (reduced functional bladder capacity) 29 . In healthy bladder, urothelial damage is rapidly repaired, but this reparative process may be lacking or deficient in IC/BPS bladder due to subsequent neurogenic inflammation 30 . In the current study, HIC bladder exhibited the most extensive loss of umbrella cell layers, tight junctions, and uroplakin plaques, indicating greatest deficiency in barrier function and suggesting that severe chronic inflammation suppresses that capacity of umbrella cells to regenerate.
Cystoscopic hydrodistention is one of the main diagnostic tools for IC/BPS 1 . Bladder glomerulation hemorrhage may result from excessive expression of vascular endothelial growth factor (VEGF) and concomitant generation of immature suburothelial vessels more prone to rupture during cystoscopic hydrodistention 31,32 . However, glomerulation hemorrhage after cystoscopic hydrodistention is not specific to IC/BPS, but may also be observed in other pathologies associated with chronic inflammation of the urothelium, such as urolithiasis, benign prostate hyperplasia, and stress urinary incontinence, as well as in asymptomatic patients 33 . Further, we found that glomerulation hemorrhage grade was associated with inflammatory cell infiltration in the lamina propria but not with other urothelial cell defects. Suburothelial inflammatory cell infiltration may indicate local active inflammation or injury, during which VEGF overexpression would increase vascular permeability, leading to glomerulation, edema, and further inflammation 34 .
TNF-α is a pleiotropic, pro-inflammatory cytokine released by mast cells in the bladder urothelium of patients with IC/BPS 35 . In a previous study, which using a transgenic mouse model to mimic IC/BPS, showed TNF-α were associated with the formation of urothelial lesions and loss of barrier function of the bladder 35 . Besides, TNF-α was shown to promote urothelial apoptosis and cause the characteristic symptoms of IC/BPS 36 . In the current study, we also found that urothelial defects and inflammatory cells accumulation at lamina propria and is common EM findings in IC/BPS bladder, which consistent with these prior rodent studies. The severity of inflammatory cell infiltration was associated with glomerulation hemorrhage grade after cystoscopic hydrodistention and the urothelium cell layer defects were associated with clinical symptom severity.
The main limitation of this study is lack of quantitative urothelial cell defect grading. In addition, the specimens were graded by a single investigator, which may introduce subjective bias. In addition, there was no standard biopsy site or tissue depth, and variations in these parameters may account for some of differences in EM findings, especially for HIC patients because bladder biopsy cannot be performed directly at the lesion. The effects of tissue crush during cold-cup biopsy and other preparation processes on urothelium EM features are also unclear. Future studies using more objective, quantitative methods such as immunofluorescence staining are needed to confirm the unique ultrastructural pathology of IC/BPS subtypes.

Conclusions
The present study revealed significantly reduced urothelial cell numbers as well as loss of umbrella cell barrier integrity in bladder samples from HIC patients. Suburothelial inflammatory cell infiltration was also common among IC/BPS patients, especially those with high-grade glomerulation. These urothelium cell layer defects on EM were strongly associated with clinical symptom severity.

Data availability
No datasets were generated or analyzed during the current study.  License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http:// creat iveco mmons. org/ licen ses/ by/4. 0/.